Cabergoline and parkinson's disease Patient Reports February 12, 2012

Cabergoline Side Effects Report #5637425-2
Cabergoline side effect was reported by a Physician from JAPAN on Feb 13, 2008. Female patient, 80 years of age, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: dyspnoea, parkinson's disease , pleural effusion. Cabergoline dosage: unknown. Patient recovered.

Cabergoline Side Effects Report #4649867-2
Cabergoline side effect was reported by a Physician from on Apr 15, 2005. Male patient, 72 years of age, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: disease progression, dystonia , parkinson's disease . Cabergoline dosage: unknown. During the same period patient was treated with MADOPAR. Patient recovered.

Cabergoline Side Effects Report #4649867-2
Cabergoline side effect was reported by a Physician from JAPAN on Apr 15, 2005. Male patient, 72 years of age, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: disease progression, dystonia , parkinson's disease . Cabergoline dosage: unknown. During the same period patient was treated with MADOPAR. Patient recovered.

Cabergoline Side Effects Report #4911994-X
Cabergoline side effect was reported by a Physician from AUSTRALIA on Feb 03, 2006. Male patient, 72 years of age, weighting 140.0 lb, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: cervical vertebral fracture, condition aggravated, delusion, fall , hypoxic encephalopathy, paranoia, parkinson's disease , physical assault. Cabergoline dosage: (2 MG), ORAL. During the same period patient was treated with COMTAN, ZESTRIL, MICARDIS HCT, SINEMET, ARTANE. Patient was hospitalized. Patient recovered.


Cabergoline Side Effects Report #4629445-1
Cabergoline side effect was reported by a Physician from on Mar 23, 2005. Male patient, 68 years of age, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: condition aggravated, dyspnoea, parkinson's disease , pleural effusion, pleural fibrosis. Cabergoline dosage: 4 MG (4 MG, DAILY), ORAL. During the same period patient was treated with MADOPAR. Patient recovered.

Cabergoline Side Effects Report #4866654-0
Cabergoline side effect was reported by a Pharmacist from UNITED KINGDOM on Dec 13, 2005. Female patient, 60 years of age, weighting 126.0 lb, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: condition aggravated, movement disorder , parkinson's disease . Cabergoline dosage: 6 MG (4 MG, ONCE DAILY), ORAL. During the same period patient was treated with SINEMET, SINEMET CR, IMIPRAMINE. Patient recovered.

Cabergoline Side Effects Report #4985929-8
Cabergoline side effect was reported by a Physician from JAPAN on Apr 11, 2006. Male patient, 57 years of age, weighting 139.3 lb, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: condition aggravated, parkinson's disease , salivary hypersecretion. Cabergoline dosage: 0.25 MG, 1 D, ORAL. During the same period patient was treated with SELEGILINE HYDROCHLORIDE, NAUZELIN, PERMAX, LEVODOPA, SYMMETREL. Patient was hospitalized. Patient recovered.

Cabergoline Side Effects Report #5356927-X
Cabergoline side effect was reported by a Consumer or non-health professional from JAPAN on June 01, 2007. Male patient, weighting 101.4 lb, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, cardiac valve disease, constipation , dyspnoea paroxysmal nocturnal, haemodynamic instability, ileus, megacolon, parkinson's disease , pyrexia. Cabergoline dosage: unknown. During the same period patient was treated with SELEGILINE, MADOPAR, SEROQUEL, THYRADIN S, GASTER, LENDORMIN, MAGNESIUM OXIDE. Patient was hospitalized. Patient recovered.

Cabergoline Side Effects Report #5085942-9
Cabergoline side effect was reported by a Health Professional from UNITED KINGDOM on Aug 03, 2006. Female patient was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: condition aggravated, parkinson's disease . Cabergoline dosage: unknown. Patient was hospitalized. Patient recovered.


Cabergoline Side Effects Report #4579898-2
Cabergoline side effect was reported by a Physician from on Jan 28, 2005. Female patient was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: condition aggravated, mitral valve incompetence, orthopnoea, parkinson's disease . Cabergoline dosage: 4 MG (4 MG, 1 IN 1 D), ORAL. During the same period patient was treated with MADOPAR, MESALAMINE. Patient was hospitalized. Patient recovered.

Cabergoline Side Effects Report #4885747-5
Cabergoline side effect was reported by a Physician from AUSTRALIA on Dec 21, 2005. Male patient was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aggression, paranoia, parkinson's disease . Cabergoline dosage: unknown. During the same period patient was treated with COMTAN. Patient was hospitalized. Patient recovered.